Merck Group’s CVC managing directors Owen Lozman and Hakan Goker speak about the transformational power of machine learning in pharma and materials science.

M Ventures' managing directors Hakan Goker and Owen Lozman explore the future of biotech and frontier technology.

Venture capital firm Bioluminescence Ventures emerges from stealth with two funds supported by institutional investors.

Ben Jacobs of Companion Fund, flush with $300m from Mars, is going against the grain and betting bigger on startups as others pull back.

After serving two years at Grifols Innovation and New Technologies, Gasol Escuer has accepted a new position at global venture firm AdBio Partners

Mars' pet food and veterinary subsidiary has teamed up with Digitalis Partners to launch a second Companion Fund, following a $100m predecessor in 2018.

The biopharmaceutical CVC unit’s new initiative will back 15 seed-stage startups a year, especially those developing AI, data and digital health technologies.

Nationwide Children's Hospital and seed-stage venture studio Rev1 are partnering to invest in a dozen healthtech startups over five years.

The monthly deals table is out for August. Browse a month's worth of CVC deals, see what was trending and what dropped off.

The unit aims to invest in startups working at the intersection of diagnostics and digital technologies.